EGF and its receptor EGFR are highly upregulated in 59.5% (22/37), and 32.4 (12/37) of patients with ICC, and these expressions showed no correlation with metastases of ICC. This evidence concerns the gene EGFR and intrahepatic cholangiocarcinoma.